It is found that Retatrutide, an anti‐obesity agent, inhibits HBP and YAP O‐GlcNAcylation leading to increased YAP degradation through the deprivation of EIF3H‐mediated deubiquitylation of YAP. The gene discussed is YAP1; the disease is obesity disorder.